Legacy Advisors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Legacy Advisors's GILD Position: Q1 2025 in Review
Legacy Advisors increased its Gilead Sciences (GILD) stake by 14% in Q1 2025, buying an estimated $53.9K and bringing the position to 4,386 shares worth $491K. The position accounts for 0.05% of the portfolio, ranked #265.
Legacy Advisors first reported a position in GILD in Q4 2016 and has held it in 16 quarters since. 2,019 funds tracked by Wall St. Rank hold GILD as of Q1 2025.
- Legacy Advisors held 4,386 shares of Gilead Sciences worth $491K as of Q1 2025.
- Legacy Advisors bought 522 Gilead Sciences shares in Q1 2025, an estimated $53.9K.
- Gilead Sciences made up 0.05% of Legacy Advisors's portfolio in Q1 2025, its #265 holding.
- Legacy Advisors first reported a position in Gilead Sciences in Q4 2016 and has held it in 16 quarters since.
- 2,019 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2025.
Based on Legacy Advisors's 13F filing for Q1 2025, filed 23 Apr 2025.